Application | Comment | Organism |
---|---|---|
drug development | UCH54, homologous to human UCH37, may represent a target for pharmacological intervention | Plasmodium falciparum |
Cloned (Comment) | Organism |
---|---|
into vector pcDNA3.1(+) in frame with a C-terminal HA epitope tag and expressed in Escherichia coli | Plasmodium falciparum |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
54000 | - |
predicted | Plasmodium falciparum |
100000 | - |
immunoprecipitation, SDS-PAGE and tandem mass spectrometry | Plasmodium falciparum |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Plasmodium falciparum | - |
3D7 strain | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | deubiquitinating as well as deNeddylating activity. Active residues are Cys145, His220 and Asp235 | Plasmodium falciparum | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
ubiquitin C-terminal hydrolase | - |
Plasmodium falciparum |
UCH54 | - |
Plasmodium falciparum |